相似文献/References:
[1]许敏.82例妊娠晚期死胎的临床分析[J].中国计划生育和妇产科,2011,(04):0.
XU Min.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(03):0.
[2]张爱臣,佟玲玲.卵巢癌的诊治进展[J].中国计划生育和妇产科,2013,(01):0.
ZHANG Ai-chen,TONG Ling-ling.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(03):0.
[3]鄢碧玉.妊娠晚期血糖水平对胎心监护的影响与分析[J].中国计划生育和妇产科,2014,(02):0.
YAN Bi-yu,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(03):0.
[4]冯学宇,赵芬.影响妊娠晚期胎头衔接的因素分析[J].中国计划生育和妇产科,2015,(09):0.
FENG Xue-yu,ZHAO Fen,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(03):0.
[5]黄晓玲,林云霞,梁敏洪,等.妊娠晚期妇女B族链球菌带菌情况与母婴预后的关系[J].中国计划生育和妇产科,2015,(10):0.
HUANG Xiao-ling,LIN Yun-xia,LIANG Min-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(03):0.
[6]李慧,汤小晗,卢美松*.肝素结合表皮生长因子与卵巢癌顺铂化疗耐药性关系的研究[J].中国计划生育和妇产科,2016,(12):15.
LI Hui,TANG Xiao-han,LU Mei-song*.Study on relationship between HB-EGF and resistance of ovarian cancer to chemotherapy drug[J].Chinese Journal of Family Planning & Gynecotokology,2016,(03):15.
[7]何丽,林永红,李笑晓,等.防己诺林碱联用紫杉醇对耐药卵巢癌SKOV3/ADM细胞作用机制的初步研究[J].中国计划生育和妇产科,2017,(6):59.
HE Li,LIN Yong-hong,LI Xiao-xiao,et al.Effect of fangchinoline combined with paclitaxel on drug resistant ovarian cancer SKOV3 / ADM cells: a preliminary study[J].Chinese Journal of Family Planning & Gynecotokology,2017,(03):59.
[8]卢丹华,洪莉*,杨将,等.Jagged1-STAT 3信号轴对卵巢癌细胞A 2780迁移能力的影响[J].中国计划生育和妇产科,2017,(8):72.
LU Dan-hua,HONG Li*,YANG Jiang,et al.Effect of Jagged1-STAT 3 signal axis on migration ability of ovarian cancer cell A 2780[J].Chinese Journal of Family Planning & Gynecotokology,2017,(03):72.
[9]张雪梅.紫杉醇联合洛铂化疗方案对晚期初治卵巢癌术后
患者早期临床疗效及毒副反应发生率的分析[J].中国计划生育和妇产科,2018,(2):72.
ZHANG Xue-mei.Early clinical efficacy and side effects of paclitaxel combined with
lobaplatin regimen on postoperative patients with advanced ovarian cancer[J].Chinese Journal of Family Planning & Gynecotokology,2018,(03):72.
[10]石亚利,梁华茂*,姚颖.腹腔镜卵巢恶性肿瘤再分期手术临床分析（附38例报道）[J].中国计划生育和妇产科,2018,(3):37.
SHI Ya-li,LIANG Hua-mao*,YAO Ying.Clinical analysis of laparoscopic restaging surgery for ovarian
malignancies (report of 38 cases)[J].Chinese Journal of Family Planning & Gynecotokology,2018,(03):37.